NCT06625892

Brief Summary

The primary objective of this two-year research project is to investigate the status of activity fear, its related factors, and prognosis in cardiac surgery patients in the first year. Subsequently, the study aims to develop a comprehensive intervention strategy combining exercise with cognitive-behavioral approaches tailored for cardiac surgery patients and assess the effectiveness of this intervention on activity fear, prognosis, and quality of life in the second year.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
245

participants targeted

Target at P75+ for not_applicable

Timeline
3mo left

Started Aug 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress88%
Aug 2024Jul 2026

Study Start

First participant enrolled

August 14, 2024

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

October 2, 2024

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 3, 2024

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2026

Last Updated

March 14, 2025

Status Verified

October 1, 2024

Enrollment Period

2 years

First QC Date

October 2, 2024

Last Update Submit

March 12, 2025

Conditions

Keywords

kinesiophobia, cardiac surgery

Outcome Measures

Primary Outcomes (1)

  • kinesiophobia

    Tampa Scale of Kinesiophobia for Heart (TSK Heart) was used for measuring kinesiophobia in this study. The TSK Heart developed by Bäck et al. (2012), assesses fear of movement in patients with coronary artery disease. It comprises four dimensions: exercise avoidance, fear of injury, dysfunctional self-perception, and perceived risk of heart problems, with 17 items. Each item is scored on a 4-point Likert scale (1 = strongly disagree to 4 = strongly agree), and items 4, 8, 12, and 16 are reverse scored. The total score ranges from 17 to 68, with higher scores indicating greater fear of movement. A TSK Heart score below 37 indicates a low fear of movement, while a score of 37 or higher indicates a high fear of movement. The scale\'s intra-class correlation coefficient is 0.83, and its internal consistency (Cronbach\'s alpha) is 0.78 (Bäck et al., 2012).

    1 day discharge, two weeks post-discharge, six weeks, 12 weeks, and 24 weeks.

Secondary Outcomes (2)

  • International Physical Activity Questionnaire (IPAQ)

    1 day discharge, two weeks post-discharge, six weeks, 12 weeks, and 24 weeks.

  • Taiwan Brief Version of the World Health Organization Quality of Life Questionnaire (WHOQOL-BREF)

    1 day discharge, two weeks post-discharge, six weeks, 12 weeks, and 24 weeks.

Study Arms (2)

the interventions group

EXPERIMENTAL

The experimental group undergoes a 12-week multidimensional interventions.

Behavioral: the multidimensional interventions

the control group

NO INTERVENTION

the control group receives no intervention.

Interventions

The study participants will receive cognitive behavior therapy intervention for six weeks, one session per week, 45 minutes each time, and exercise training for twelve weeks, twice sessions per week, 60 minutes each time.

the interventions group

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients received cardiac surgery.
  • Aged 18 or above.
  • Clear consciousness and able to communicate in Mandarin or Taiwanese.
  • Willing and consent to participate after being informed of the study purpose and procedures.

You may not qualify if:

  • Cognitive impairment,
  • Psychiatric disorders, and
  • Long-term bedridden patients who rely on others for daily activities.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Changhua Christian Hospital

Changhua, Taiwan

RECRUITING

MeSH Terms

Conditions

Kinesiophobia

Condition Hierarchy (Ancestors)

Phobic DisordersAnxiety DisordersMental Disorders

Study Officials

  • Wan-Ting Huang, PhD

    Da-Yeh University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Chang Ai-Ling, Master

CONTACT

Wan-Ting Huang, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The outcome assessors dose not know the allocation of groups.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: The first-year research adopts a descriptive, correlational, and repeated-measures design, while the second-year research employs an experimental design. Participants are randomly assigned to either the experimental or control group. The experimental group undergoes a 12-week comprehensive intervention, while the control group receives no intervention.
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Supervisor

Study Record Dates

First Submitted

October 2, 2024

First Posted

October 3, 2024

Study Start

August 14, 2024

Primary Completion (Estimated)

July 31, 2026

Study Completion (Estimated)

July 31, 2026

Last Updated

March 14, 2025

Record last verified: 2024-10

Locations